Puration Inc (PURA)

[Multi_Pennies]

From Todays PR.,

Dallas, TX -- February 26, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today announced an upcoming analyst update report expected to be published this Thursday, February 28, 2019. The report expected on Thursday will be a second update from Goldman Small Cap Research which initiated analyst coverage in October last year and published a first update in November of last year confirming a Speculative Buy and $0.25 Target PPS. The company has since the first update signed additional contracts and launched an all new formulation and packaging of its EVERx CBD Sports Water. Earlier today, the company previewed a major coming announcement regarding its EVERx CBD Sports Water planned for release later this week. The previewed announcement expected later this week is separate from the Analyst Report update planned for release on Thursday this week. The update report is anticipated to include an assessment of PURA’s $1.5 million contract with Generex Biotechnology (USOTC: GNBT) to produce custom, private ladled, CBD Infused water for Generex. PURA is working with Kali-Extracts (USOTC: KALY) to develop the customer CBD extract formulation for infusion into the water produced for Generex.